What is the translation of " DOCETAXEL IN COMBINATION " in Slovenian?

• docetaksel v kombinaciji
• zdravilo docetaksel teva v kombinaciji
• docetakselom v kombinaciji
• docefrez v kombinaciji

Examples of using Docetaxel in combination in English and their translations into Slovenian

Docetaxel in combination with trastuzumab.
Docefrez v kombinaciji s trastuzumabom.

Patients who received docetaxel in combination with cisplatin.
Bolnikih, ki so dobivali docetaksel v kombinaciji s cisplatinom;

Docetaxel in combination with capecitabine.
Docefrez v kombinaciji s kapecitabinom.

Patients who received docetaxel in combination with doxorubicin.
Bolnikih, ki so dobivali docetaksel v kombinaciji z doksorubicinom;

Docetaxel in combination with trastuzumab.
Docetaksel v kombinaciji s trastuzumabom.

Patients treated with docetaxel in combination with trastuzumab.
Bolnikih, ki so prejemale docetaksel v kombinaciji s trastuzumabom.

Docetaxel in combination with capecitabine.
Docetaksel v kombinaciji s kapecitabinom.

Patients treated with docetaxel in combination with trastuzumab.
Bolnicah, ki so prejemale docetaksel v kombinaciji s trastuzumabom.

Docetaxel in combination with doxorubicin.
Docetaksel v kombinaciji z doksorubicinom.

No data are available in patients with hepatic impairment treated by docetaxel in combination in the other indications.
Za bolnike z okvaro jeter, zdravljene z docetakselom v kombinaciji pri drugih indikacijah, ni podatkov.

Docetaxel in combination with trastuzumab.
Zdravilo Docetaksel Teva v kombinaciji s trastuzumabom.

No data are available in patients with hepatic impairment treated by docetaxel in combination in the other indications.
Za bolnike z okvaro jeter, ki se zdravijo z docetakselom v kombinaciji pri drugih indikacijah, ni podatkov.

Docetaxel in combination with capecitabine.
Zdravilo Docetaksel Teva v kombinaciji s kapecitabinom.

When patients are candidates for treatment with docetaxel in combination with trastuzumab, they should undergo baseline cardiac assessment.
Pri bolnicah, ki so kandidatke za zdravljenje z docetakselom v kombinaciji s trastuzumabom, je treba opraviti izhodiščne preiskave za oceno srčne funkcije.

Docetaxel in combination with doxorubicin.
Zdravilo Docetaksel Teva v kombinaciji z doksorubicinom.

Patients(744 and 532 in TAX 316 and GEICAM 9805 respectively) who received docetaxel in combination with doxorubicin and cyclophosphamide(clinically important treatment related adverse events are presented).
Bolnikih(744 pri TAX 316 in 532 GEICAM 9805), ki so prejemali docetaksel v kombinaciji z doksorubicinom in ciklofosfamidom(predstavljeni so klinično pomembni z zdravljenjem povezani neželeni učinki).

Docetaxel in combination with doxorubicin and cyclophosphamide: adjuvant therapy.
Docefrez v kombinaciji z doksorubicinom in ciklofosfamidom: adjuvantno zdravljenje.

Gastric adenocarcinoma patients(221 patients in the phase III part of the study and 79 patients in the phase II part) who received docetaxel in combination with cisplatin and 5-fluorouracil(clinically important treatment related adverse events are presented).
Bolnikih z adenokarcinomom ţelodca(221 bolnikov v III. fazi študije in 79 bolnikov v II. fazi študije), ki so dobivali docetaksel v kombinaciji s cisplatinom in 5 -fluorouracilom(navedeni so klinično pomembni, z zdravljenjem povezani, neţeleni učinki);

Docetaxel in combination with doxorubicin and cyclophosphamide: adjuvant therapy.
Zdravilo Docetaksel Teva v kombinaciji z doksorubicinom in ciklofosfamidom: adjuvantno zdravljenje.

Among the 300(221 patients in the phase III part of the study and 79 patients in the phase II part) patients treated with docetaxel in combination with cisplatin and 5-fluorouracil in the gastric cancer study, 74 were 65 years of age or older and 4 patients were 75 years of age or older.
Med 300 bolniki(221 bolnikov v III. fazi študije in 79 bolnikov v II. fazi študije), ki so se zdravili z docetakselom v kombinaciji s cisplatinom in 5-fluorouracilom v študiji raka ţelodca, je bilo bolnikov starih 65 let ali več, 4 pa so bili stari 75 let ali več.

Docetaxel in combination with platinum agents in chemotherapy-naïve patients.
Zdravilo Docetaksel Teva v kombinaciji s platinskimi zdravili pri bolnikih, ki se še niso zdravili s kemoterapijo.

The adverse reactions considered to be possibly or probably related to the administration of docetaxel have been obtained in:• 1312 and 121 patients who received 100 mg/ m² and 75 mg/ m² of docetaxel as a single agent respectively.• 258 patients who received docetaxel in combination with doxorubicin.• 406 patients who received docetaxel in combination with cisplatin.• 92 patients treated with docetaxel in combination with trastuzumab.
Podatki o neželenih učinkih, ki so morda ali verjetno povezani z uporabo docetaksela, so bili zbrani pri:• 1312 bolnikih, ki so v monoterapiji prejemali 100 mg/ m² docetaksela, 121 pa jih je prejemalo 75 mg/ m².• 258 bolnikih, ki so prejemali docetaksel v kombinaciji z doksorubicinom.• 406 bolnikih, ki so prejemali docetaksel v kombinaciji s cisplatinom.• 92 bolnicah, ki so prejemale docetaksel v kombinaciji s trastuzumabom.

Patients who received docetaxel in combination with prednisone or prednisolone(clinically important treatment related adverse events are presented).
Bolnikih, ki so dobivali docetaksel v kombinaciji s prednizonom ali prednizolonom(predstavljeni so klinično pomembni, z zdravljenjem povezani, neţeleni učinki);

And 251 head and neck cancer patients who received docetaxel in combination with cisplatin and 5-fluorouracil(clinically important treatment related adverse events are presented).
In 251 bolnikih z rakom glave in vratu, ki so dobivali docetaksel v kombinaciji s cisplatinom in 5-fluorouracilom(navedeni so klinično pomembni, z zdravljenjem povezani, neţeleni učinki).